Journal
GENES CHROMOSOMES & CANCER
Volume 40, Issue 1, Pages 51-54Publisher
WILEY
DOI: 10.1002/gcc.20017
Keywords
-
Categories
Funding
- NCI NIH HHS [CA84955, T32 CA93245-01] Funding Source: Medline
Ask authors/readers for more resources
Alterations in estrogen responsive pathways are thought to contribute to benign and malignant breast disease. It has been reported previously that more than a third of typical epithelial hyperplasia lesions harbor the missense mutation A908G in the estrogen receptor alpha (ESR1) gene. This substitution of an arginine for a lysine at codon 303 was reported to confer mitogenic hypersensitivity to estrogen. To explore this finding further, we analyzed ESR1 for this mutation in a series of breast tissues ranging from typical hyperplasia to invasive cancer. In contrast to previous studies, no evidence for this mutation was found in 36 invasive cancers, 11 in situ carcinomas, 14 epithelial hyperplasias with atypia, 11 epithelial hyperplasias without atypia, and 11 breast cancer cell lines. These results indicate that ESR/ mutant A908G does not occur with significant frequency in either benign or malignant proliferations of breast epithelia. (C) 2004 Wiley-Liss, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available